OTCMKTS:CRLBF Cresco Labs (CRLBF) Stock Price, News & Analysis $0.45 -0.02 (-4.64%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsNews and TrendsSEC FilingsShort Interest About Cresco Labs Stock (OTCMKTS:CRLBF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cresco Labs alerts:Sign Up Key Stats Today's Range$0.45▼$0.5050-Day Range$0.45▼$0.7952-Week Range$0.45▼$2.30Volume848,569 shsAverage Volume702,001 shsMarket Capitalization$167.59 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingBuy Company Overview Cresco Labs is a U.S. cannabis company founded in Chicago in 2013. It cultivates and processes cannabis, manufactures branded products, and sells through wholesale channels and its own retail stores in licensed markets. The company’s product portfolio includes cannabis flower, vapes, concentrates, edibles and other cannabis products. Its brands include Cresco, High Supply, FloraCal and Good News, and it operates retail dispensaries under the Sunnyside name. Cresco Labs serves both medical and adult-use cannabis customers, with operations spanning multiple U.S. states. Its activities are subject to state-specific cannabis laws and regulations.AI Generated. May Contain Errors. Read More Cresco Labs Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks23rd Percentile Overall ScoreCRLBF MarketRank™: 1.16132101114 of 5 starsCresco Labs scored higher than 23% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.7 / 5Analyst RatingBuy Consensus RatingCresco Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageCresco Labs has only been the subject of 1 research reports in the past 90 days.Read more about Cresco Labs' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Earnings GrowthEarnings for Cresco Labs are expected to remain at ($0.07) per share in the coming year.Price to Book Value per Share RatioCresco Labs has a P/B Ratio of 0.66. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.29% of the float of Cresco Labs has been sold short.Short Interest Ratio / Days to CoverCresco Labs has a short interest ratio ("days to cover") of 1.38, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cresco Labs has recently decreased by 21.86%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCresco Labs does not currently pay a dividend.Dividend GrowthCresco Labs does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A Search InterestOnly 3 people have searched for CRLBF on MarketBeat in the last 30 days. This is a decrease of -85% compared to the previous 30 days.MarketBeat Follows3 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cresco Labs insiders have not sold or bought any company stock.Percentage Held by Institutions0.05% of the stock of Cresco Labs is held by institutions.Read more about Cresco Labs' insider trading history. Receive CRLBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CRLBF Stock News HeadlinesCresco Labs Inc. (CRLBF) Q3 2026 Earnings Call TranscriptNovember 6, 2026 | seekingalpha.comCresco Labs Q1 Net Loss NarrowsNovember 6, 2026 | rttnews.comYou missed yesterday's deadline…In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.November 18 at 1:00 AM | Behind the Markets (Ad)Cresco Labs Reports Third Quarter 2026 Financial ResultsNovember 6, 2026 | businesswire.comCresco Labs Advances Innovation Pipeline with High Supply SLIPS and Wonder THC Drink MixesNovember 5, 2026 | businesswire.comCresco Labs Celebrates Sunnyside Prestonsburg Grand Opening, Marking Major Milestone for Kentucky Medical CannabisOctober 23, 2026 | financialpost.comFCresco Labs Celebrates Sunnyside Prestonsburg Grand Opening, Marking Major Milestone for Kentucky Medical CannabisOctober 23, 2026 | businesswire.comCresco Labs Sets November 6 Date to Report Q3 2026 EarningsOctober 15, 2026 | tipranks.comSee More Headlines CRLBF Stock Analysis - Frequently Asked Questions How have CRLBF shares performed this year? Cresco Labs' stock was trading at $1.23 at the beginning of the year. Since then, CRLBF stock has decreased by 63.4% and is now trading at $0.4501. How were Cresco Labs' earnings last quarter? Cresco Labs Inc. (OTCMKTS:CRLBF) posted its quarterly earnings results on Friday, November, 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by $0.01. The firm earned $172.78 million during the quarter, compared to analyst estimates of $173.66 million. Cresco Labs had a negative net margin of 14.61% and a negative trailing twelve-month return on equity of 6.36%. How do I buy shares of Cresco Labs? Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cresco Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cresco Labs investors own include Curaleaf (CURLF), Trulieve Cannabis (TCNNF), Green Thumb Industries (GTBIF), Canopy Growth (CGC), Tilray Brands (TLRY), NVIDIA (NVDA) and Aurora Cannabis (ACB). Company Calendar Last Earnings11/06/2026Today11/18/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:CRLBF CIK1832928 Webwww.crescolabs.com Phone312-929-0993FaxN/AEmployees2,900Year Founded2013Profitability EPS (Trailing Twelve Months)($0.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$135.41 million Net Margins-14.61% Pretax Margin-14.93% Return on Equity-6.36% Return on Assets-1.31% Debt Debt-to-Equity Ratio1.86 Current Ratio2.27 Quick Ratio1.28 Sales & Book Value Annual Sales$655.85 million Price / Sales0.26 Cash Flow$0.04 per share Price / Cash Flow12.26 Book Value$0.68 per share Price / Book0.66Miscellaneous Outstanding Shares372,350,000Free FloatN/AMarket Cap$167.59 million OptionableNot Optionable Beta1.60 Social Links Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (OTCMKTS:CRLBF) was last updated on 11/18/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cresco Labs Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cresco Labs With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.